Taxotere (docetaxel) is being launched for advanced breast cancer

Taxotere (docetaxel) is being launched for advanced breast Rhone-Poulenc Rorer.

Taxotere is similar to Taxol (paclitaxel) works as well as Taxol for anthracycline-resistant breast cancer. But it causes severe neutropenia, hypersensitivity reactions, and fluid retention.

Watch for significant drug interactions in patients on Taxotere. It's metabolized by the same cytochrome P450 liver enzyme (CYP3A4) as terfenadine (Seldane), ketoconazole, erythromycin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote